QNRX vs ILAG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
QNRX Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) driven by superior Valuation, Growth & Margin while ILAG counters with relative strength in Momentum & Technical. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ILAG at N/M Forward P/E and -279.6% operating margin (+2.3% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ILAG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | QNRX | ILAG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $16.1M | $3.3M | Larger Scale | QNRX |
| Trailing P/E Ratio Valuation | 7.6x | N/M | Lower Multiple | QNRX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +2.3% | Higher Growth | ILAG |
| Operating Margin (TTM) Profitability | 0.0% | -279.6% | Higher Margin | QNRX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -142.6% | -215.3% | Higher ROE | QNRX |
| 52-Week Range Position Momentum | 0% ($3โ$24) | 18% ($0โ$7) | Stronger Trend | ILAG |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 74% Vol | 0.81ฮฒ ยท 94% Vol | Lower Realized Risk | QNRX |
| Unified Institutional Score Composite Signal | 46.1 / 100 (HOLD) | 49.6 / 100 (HOLD) | Higher Composite | ILAG |